These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. Luciani A; Villella VR; Vasaturo A; Giardino I; Raia V; Pettoello-Mantovani M; D'Apolito M; Guido S; Leal T; Quaratino S; Maiuri L J Immunol; 2009 Aug; 183(4):2775-84. PubMed ID: 19625650 [TBL] [Abstract][Full Text] [Related]
3. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Luciani A; Villella VR; Esposito S; Brunetti-Pierri N; Medina D; Settembre C; Gavina M; Pulze L; Giardino I; Pettoello-Mantovani M; D'Apolito M; Guido S; Masliah E; Spencer B; Quaratino S; Raia V; Ballabio A; Maiuri L Nat Cell Biol; 2010 Sep; 12(9):863-75. PubMed ID: 20711182 [TBL] [Abstract][Full Text] [Related]
4. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation. Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850 [TBL] [Abstract][Full Text] [Related]
6. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928 [TBL] [Abstract][Full Text] [Related]
7. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis. Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365 [TBL] [Abstract][Full Text] [Related]
11. Lung arginase expression and activity is increased in cystic fibrosis mouse models. Jaecklin T; Duerr J; Huang H; Rafii M; Bear CE; Ratjen F; Pencharz P; Kavanagh BP; Mall MA; Grasemann H J Appl Physiol (1985); 2014 Aug; 117(3):284-8. PubMed ID: 24925982 [TBL] [Abstract][Full Text] [Related]
12. The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology. Hardy CL; King SJ; Mifsud NA; Hedger MP; Phillips DJ; Mackay F; de Kretser DM; Wilson JW; Rolland JM; O'Hehir RE Immunol Cell Biol; 2015 Jul; 93(6):567-74. PubMed ID: 25753271 [TBL] [Abstract][Full Text] [Related]
13. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. Maiuri L; Luciani A; Giardino I; Raia V; Villella VR; D'Apolito M; Pettoello-Mantovani M; Guido S; Ciacci C; Cimmino M; Cexus ON; Londei M; Quaratino S J Immunol; 2008 Jun; 180(11):7697-705. PubMed ID: 18490773 [TBL] [Abstract][Full Text] [Related]
14. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931. Veltman M; Stolarczyk M; Radzioch D; Wojewodka G; De Sanctis JB; Dik WA; Dzyubachyk O; Oravecz T; de Kleer I; Scholte BJ Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L1000-L1014. PubMed ID: 27663991 [TBL] [Abstract][Full Text] [Related]
15. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease. Mall MA Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118 [TBL] [Abstract][Full Text] [Related]
16. Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. Bergamini G; Cigana C; Sorio C; Della Peruta M; Pompella A; Corti A; Huaux FA; Leal T; Assael BM; Melotti P Am J Respir Cell Mol Biol; 2009 Aug; 41(2):199-206. PubMed ID: 19097986 [TBL] [Abstract][Full Text] [Related]